#95 – A to Z on R&D: Challenges and Solutions for Sustained Antimicrobial Drug Development
Breakpoints29 Mars 2024

#95 – A to Z on R&D: Challenges and Solutions for Sustained Antimicrobial Drug Development

In this episode, Drs. Helen Boucher (@hboucher3), Ramy Elshaboury, and Mike Dudley (@MikeMNDudley) join host, Megan Klatt (@MeganKlatt3), to discuss barriers to antimicrobial drug development, potential incentives and legislation to promote market growth, and what we can do to ensure the antimicrobial pipeline doesn’t run dry.

Learn more about the Society of Infectious Diseases Pharmacists: https://sidp.org/About X: @SIDPharm (https://twitter.com/SIDPharm) Instagram: @SIDPharm (https://www.instagram.com/sidpharm/) Facebook: https://www.facebook.com/sidprx LinkedIn: https://www.linkedin.com/company/sidp

References

  1. An analysis of antibacterial drug development trends in the United States, 1980-2019: Dheman N, et al. Clin Infect Dis. 2021 Dec 6;73(11):e4444-e4450. doi:10.1093/cid/ciaa859. PMID: 32584952.
  2. Antibacterial R&D at a crossroads: we’ve pushed as hard as we can…now we need to start pulling!: Rex JH, Outterson K. Clin Infect Dis. 2021 Dec 6;73(11):e4451-4453. doi:10.1093/cid/ciaa852. PMID: 32584949.
  3. No Patient Left Behind (website): https://www.nopatientleftbehind.org/ (many useful explainers of how the investment, innovation cycle, and drug pricing work)
  4. ISPOR special task force report on defining elements of value in health care – a health economics approach: Lakdawalla DN, et al. Value Health. 2018 2018 Feb;21(2):131-139. doi: 10.1016/j.jval.2017.12.007. PMID: 29477390.
  5. Generalized cost-effectiveness analysis to assess treatment value in hepatitis C: Chou JW, et al. Am J Manag Care. 2023 Dec;29(12):696-703. doi: 10.37765/ajmc.2023.89468. PMID: 38170486.

Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(142)

#142 – Does oseltamivir harm critically ill patients? The REMAP-CAP results

#142 – Does oseltamivir harm critically ill patients? The REMAP-CAP results

Does oseltamivir harm critically ill patients with influenza? In this Breakpoints and Communicable collaboration, Erin McCreary and Josh Davis are joined by Steve Webb and Steve Tong to discuss the RE...

20 Sep 1h 3min

#141 – Prostatitis: Hard to Reach, Harder to Treat

#141 – Prostatitis: Hard to Reach, Harder to Treat

Dr. Prathit Kulkarni, lead author of a recent state-of-the-art review on acute and chronic bacterial prostatitis, joins host Dr. Erin McCreary to discuss this complex disease state. They walk through ...

11 Sep 58min

#140 – Beta-lactamase inhibitors: “Scientifically elegant, just complex"

#140 – Beta-lactamase inhibitors: “Scientifically elegant, just complex"

Gram-negative resistance is beautifully intricate, scientifically elegant, and very complex. Nothing is more exciting than the recently approved and bursting pipeline of beta-lactamase inhibitors. Lis...

21 Aug 1h 16min

#139 – The ART of HIV Care: Evidence, Pearls and Practice

#139 – The ART of HIV Care: Evidence, Pearls and Practice

Join Dr.  Whitney Buckel and leading HIV experts Dr. William Short and Dr. Ryan Tomlin for an engaging discussion on the current and future state of HIV care. As treatment and prevention options conti...

31 Juli 1h 9min

#138 – You CAN Go Home Again: A review of OPAT and CoPAT from the MAD-ID/SIDP Annual Meeting

#138 – You CAN Go Home Again: A review of OPAT and CoPAT from the MAD-ID/SIDP Annual Meeting

In this must-listen episode, Dr. Ryan Moenster is joined by Dr. Monica Mahoney and Dr. Mark Gilchrist to dive deep into the evolving landscape of outpatient parenteral antimicrobial therapy (OPAT) and...

3 Juli 1h 14min

#137 – Hot Topics: What You May Have Missed in Infectious Diseases 2025-2026 (LIVE from MAD-ID)

#137 – Hot Topics: What You May Have Missed in Infectious Diseases 2025-2026 (LIVE from MAD-ID)

In this must-listen episode, Dr. Ryan Moenster and Dr. Megan Klatt dive deep into the latest infectious diseases trials, guidelines, and novel therapeutics. Staying current in the field is a challenge...

19 Juni 1h 8min

#136 – GAS, Streptococcus pyogenes: Call It What You Want, It’s Got a Big Reputation

#136 – GAS, Streptococcus pyogenes: Call It What You Want, It’s Got a Big Reputation

Group A Streptococcal infections remain a global challenge, spanning common conditions like pharyngitis to severe invasive disease. Dr. Shiranee Sriskandan, Dr. Josh Osowicki, and Dr. Tom Parks join h...

5 Juni 1h 25min

#135 – Stewie Struggles: Small Hospital Edition

#135 – Stewie Struggles: Small Hospital Edition

Small hospitals bring unique stewardship challenges, but also unique opportunities. Dr. Tina Khadem and Dr. Ashley Cubillos join host Dr. Whitney Buckel to discuss the realities of antimicrobial stewa...

22 Maj 1h 2min

Populärt inom Utbildning

historiepodden-se
det-skaver
rss-bara-en-till-om-beroende-medberoende
nu-blir-det-historia
harrisons-dramatiska-historia
not-fanny-anymore
johannes-hansen-podcast
allt-du-velat-veta
rss-viktmedicinpodden
roda-vita-rosen
sa-in-i-sjalen
rikatillsammans-om-privatekonomi-rikedom-i-livet
rss-foraldramotet-bring-lagercrantz
rss-max-tant-med-max-villman
i-vantan-pa-katastrofen
rss-traningsklubben
sektledare
rss-basta-livet
rss-autismandan
rss-okrystat